# Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata

> **NCT02216435** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 14 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02216435
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2021-02-22
- **Final completion:** 2021-02-22
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216435, "Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02216435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*